OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HMAM$629.1055

Hamama Meir Trading 1996 Ltd

Food Retail & DistributionVerified

Hamama Meir Trading 1996 Ltd has a market capitalization of ILS 8.92 billion, with a market price of ILS 629.1 per share. The company has 14.19 million shares outstanding, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability and returns are not directly quantifiable due to the lack of detailed financial metrics in the provided data. Typically, in the Food Retail & Distribution industry, key metrics include gross margin, operating margin, and return on invested capital (ROIC). Without these, a direct comparison to industry medians is not possible. The company's geographic and segment exposure is not explicitly detailed in the available data. In the Food & Drug Retailing sector, revenue concentration by region or product line is a critical factor for assessing risk and growth potential. The absence of such data limits the ability to evaluate Hamama Meir's exposure to regional or product-specific risks. Growth trajectory is also not quantifiable due to the lack of historical revenue data and forward-looking guidance. In the Food Retail & Distribution industry, growth is typically driven by market expansion, new store openings, and e-commerce adoption. Without these metrics, it is difficult to assess Hamama Meir's growth potential. Risk factors include the inability to assess liquidity risk, which is a concern for any retail business with limited financial disclosures. The company is currently assessed as having low dilution risk, but the absence of balance-sheet inputs and going-concern language in source documents raises concerns about its financial health. Recent events and filings are not detailed in the available data. In the Food & Drug Retailing sector, key events include regulatory changes, supply chain disruptions, and competitive pressures. Without specific information on recent filings or transcripts, it is difficult to assess the company's current strategic direction.

30-day price · HMAM+66.40 (+12.0%)
Low$548.00High$640.60Close$620.20As of17 May, 00:00 UTC
Profile
CompanyHamama Meir Trading 1996 Ltd
TickerHMAM.TA
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Hamama Meir Trading 1996 Ltd operates in the food retail and distribution sector, primarily generating revenue through the sale of food and drug products to consumers.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, specifically in the Food & Drug Retailing business sector, with a high confidence level of 0.92.

Hamama Meir Trading 1996 Ltd has a market capitalization of ILS 8.92 billion, with a market price of ILS 629.1 per share. The company has 14.19 million shares outstanding, with no dilution observed between basic and diluted shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's profitability and returns are not directly quantifiable due to the lack of detailed financial metrics in the provided data. Typically, in the Food Retail & Distribution industry, key metrics include gross margin, operating margin, and return on invested capital (ROIC). Without these, a direct comparison to industry medians is not possible. The company's geographic and segment exposure is not explicitly detailed in the available data. In the Food & Drug Retailing sector, revenue concentration by region or product line is a critical factor for assessing risk and growth potential. The absence of such data limits the ability to evaluate Hamama Meir's exposure to regional or product-specific risks. Growth trajectory is also not quantifiable due to the lack of historical revenue data and forward-looking guidance. In the Food Retail & Distribution industry, growth is typically driven by market expansion, new store openings, and e-commerce adoption. Without these metrics, it is difficult to assess Hamama Meir's growth potential. Risk factors include the inability to assess liquidity risk, which is a concern for any retail business with limited financial disclosures. The company is currently assessed as having low dilution risk, but the absence of balance-sheet inputs and going-concern language in source documents raises concerns about its financial health. Recent events and filings are not detailed in the available data. In the Food & Drug Retailing sector, key events include regulatory changes, supply chain disruptions, and competitive pressures. Without specific information on recent filings or transcripts, it is difficult to assess the company's current strategic direction.
Key takeaways
  • The company operates in the Food Retail & Distribution industry with a high classification confidence.
  • Market capitalization is ILS 8.92 billion, with no dilution observed between basic and diluted shares.
  • Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
  • Profitability and returns metrics are not available, limiting the ability to compare with industry medians.
  • Growth trajectory and revenue concentration data are not provided, making it difficult to assess expansion potential.
  • Recent events and filings are not detailed, limiting insight into the company's strategic direction.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyILS
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$277.4M$17.9M$16.1M$20.2M
FY-3$299.8M$5.4M-$3.5M$276.0k
FY-2$272.1M$9.4M$3.1M$9.7M
FY-1$243.7M$8.3M$4.4M$10.8M
FY0$249.8M$14.8M$14.9M$21.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$210.0M$89.4M
FY-3$228.4M$84.3M
FY-2$176.1M$87.4M
FY-1$171.6M$91.9M
FY0$189.9M$106.9M
PeriodOCFCapExFCFSBC
FY-4$24.2M-$105.0k$20.2M
FY-3-$28.7M-$525.0k$276.0k
FY-2$48.0M-$20.0k$9.7M
FY-1$27.6M-$132.0k$10.8M
FY0-$7.5M-$149.0k$21.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price$629.10
Market cap$8.92B
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricHMAMActivity
Op margin3.1% medp25 1.2% · p75 6.8%
Net margin2.0% medp25 0.7% · p75 4.1%
Gross margin26.1% medp25 17.2% · p75 32.0%
CapEx / revenue-2.5% medp25 -4.6% · p75 -1.4%
Debt / equity56.0% medp25 16.8% · p75 121.1%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 01:42 UTC#fba650a9
Market quoteclose ILS 612.70 · shares 0.01B diluted
no public URL
2026-05-08 01:42 UTC#f3633ba5
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 03:22 UTCJob: 73ec1e47